Uncommon case of pericardial effusion

We present the case of a 59-year-old patient with severe aortic stenosis, asymptomatic mild to moderate pericardial effusion and no major risk factors for poor prognosis. He underwent four-week course of non-steroidal anti-inflammatory drugs (ibuprofen 600 mg TID) with no improvement of the effusion. After complete diagnostic work-up and examination, we discovered that he had a prostate cancer with bone metastasis. On the bone scintigraphy, there was particular involvement of ribs and sternum. We decided to treat our patient with an association of docetaxel and hormone therapy, after six months we observed a reduction in the pericardial effusion. Even in the presence of a patient without risk factor of poor prognosis, pericardial effusion can be the first sign of occult neoplasia.

[1]  R. Laing,et al.  Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial , 2016, The Lancet.

[2]  K. Swedberg,et al.  Wytyczne ESC dotyczące rozpoznawania i leczenia chorób osierdzia w 2015 roku , 2015 .

[3]  Y. Adler,et al.  The 2015 ESC Guidelines on the diagnosis and management of pericardial diseases. , 2015, European heart journal.

[4]  A. Ristic,et al.  Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis , 2013, Heart Failure Reviews.

[5]  Y. Adler,et al.  Management of pericardial effusion. , 2013, European heart journal.

[6]  S. Hutchison,et al.  Malignant pericardial effusion in a patient with prostate adenocarcinoma , 2012, BMJ Case Reports.

[7]  M. Imazio Contemporary management of pericardial diseases , 2012, Current opinion in cardiology.

[8]  MassimoImazio,et al.  Indicators of Poor Prognosis of Acute Pericarditis , 2007 .

[9]  M. Sissons,et al.  A Rare Case of Cardiac Tamponade Due to Metastatic Cancer of the Prostate , 2006 .

[10]  M. Imazio,et al.  Relation of acute pericardial disease to malignancy. , 2005, The American journal of cardiology.

[11]  D. Baim,et al.  Pericardial effusion in patients with cancer: outcome with contemporary management strategies. , 1996, Heart.

[12]  C. O'connor,et al.  Etiology of large pericardial effusions. , 1993, The American journal of medicine.

[13]  D. Spodick,et al.  Contemporary Reviews in Cardiovascular Medicine Controversial Issues in the Management of Pericardial Diseases , 2010 .